1. Kodiak Sciences will present at the Jefferies Global Healthcare Conference. 2. The presentation is scheduled for June 5, 2025. 3. Kodiak focuses on developing therapies for retinal diseases. 4. Their pipeline includes three assets targeting Phase 3 data in 2026.
Participation in major healthcare events often increases visibility, attracting investors. Historical examples show that similar presentations lead to stock uptrends for biotech firms.
The presentation may boost confidence in KOD's pipeline and attract key investors, aligning with their strategic goals.
The upcoming data release in 2026 could significantly alter investor sentiment and valuation, akin to other biopharma timelines.
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that Victor Perlroth, M.D., Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City, NY on Thursday, June 5, 2025, at 9:20am ET (6:20am PT).
A live webcast of the presentation will be available on the "Events and Presentations" section of Kodiak's website at http://ir.kodiak.com/ and will remain available for replay for a limited time following the event.
Kodiak Sciences (Nasdaq: KOD) is a precommercial retina focused biotechnology company committed to researching, developing, and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC Platform® uses molecular engineering to merge the fields of protein-based and chemistry-based therapies and is at the core of Kodiak's discovery engine. Kodiak's maturing pipeline includes three late-phase clinical assets, all three targeting Phase 3 topline data in 2026.
For more information, please visit www.kodiak.com.
Kodiak®, Kodiak Sciences®, ABC®, ABC Platform®, ABCD™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.
SOURCE Kodiak Sciences Inc.